Beijing Luzhu Biotechnology Co., Ltd. - B - H Shares Stock: price and insider trades · Hong Kong
Beijing Luzhu Biotechnology Co., Ltd. - B - H Shares: what insiders have been doing
Beijing Luzhu Biotechnology Co., Ltd. - B - H Shares is a Health Care company. Its directors and officers file their transactions with HKEX. The last twelve months, up to 24 October 2026, brought 3 filings signed by 3 insiders.
All open-market trades in the period are sales: 3 sales worth €379k, by 3 insiders, with no purchase on record. Biggest ticket of the year: €126k, sold by Zhang Yanping and made public on 13 August 2026.
Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Across the 1,315 companies tracked on its exchange, the median is 4 filings; at 3 filings, this issuer sits below that mark. The full history, which starts in 2026, counts no purchases against 3 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from HKEX. Past trades are no guide to future returns.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 50,000 shares@ HK$23.00100.0% of flowShareXHKGHKEX:DA20260813E00207
- 50,000 shares@ HK$23.00100.0% of flowShareXHKGHKEX:DA20260812E00405
- 50,000 shares@ HK$23.00100.0% of flowShareXHKGHKEX:DA20260812E00440
3 of 3 declarations
About Beijing Luzhu Biotechnology Co., Ltd. - B - H Shares
Beijing Luzhu Biotechnology Co., Ltd. is a biotechnology company that provides innovative solutions in the healthcare sector. It is listed as B - H Shares on the financial market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
